Reciprocal occupancy of BCL6 and STAT5 on Growth Hormone target genes: Contrasting transcriptional outcomes and promoter-specific roles of p300 and HDAC3

Molecular and Cellular Endocrinology

Volumn 395, Issue 1-2, 2014, Pages 19-31

  Lin, Grace ^a,b   LaPensee, Christopher R ^b   Qin, Zhaohui S ^c   Schwartz, Jessica ^b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c EMORY UNIVERSITY   (United States)

Author keywords

Adipocytes; ChIP Seq; Cish; Co activator; Co repressor; Socs2

Indexed keywords

E1A ASSOCIATED P300 PROTEIN; GROWTH HORMONE; HISTONE DEACETYLASE 3; PROTEIN BCL 6; STAT5 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 2; BCL6 PROTEIN, MOUSE; DNA BINDING PROTEIN; EP300 PROTEIN, MOUSE; HISTONE DEACETYLASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BCL 6 GENE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; CYTOKINE INDUCIBLE SH2 CONTAINING PROTEIN GENE; GENE; GENE ACTIVATION; GENE EXPRESSION; GENE REPRESSION; GENETIC TRANSCRIPTION; HISTONE ACETYLATION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; SUPPRESSOR OF CYTOKINE SIGNALING 2 GENE; ANIMAL; CELL LINE; DNA RESPONSIVE ELEMENT; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHYSIOLOGY;

ANIMALS; CELL LINE; DNA-BINDING PROTEINS; E1A-ASSOCIATED P300 PROTEIN; GENE EXPRESSION REGULATION; GROWTH HORMONE; HISTONE DEACETYLASES; MICE; RESPONSE ELEMENTS; STAT5 TRANSCRIPTION FACTOR; TRANSCRIPTION, GENETIC;

EID: 84906056609     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2014.07.020     Document Type: Article

References (110)

1. Adhikari A., Sen A., Brumbaugh R.C., Schwartz J. Altered growth patterns of a mountain Ok population of Papua New Guinea over 25 years of change. Am. J. Hum. Biol 2011, 23:325-332.
2. Ahmed S.F., Farquharson C. The effect of GH and IGF1 on linear growth and skeletal development and their modulation by SOCS proteins. J. Endocrinol 2010, 206:249-259.
3. Albertsson-Wikland K., Rosberg S. Analyses of 24-hour growth hormone profiles in children: relation to growth. J. Clin. Endocrinol. Metab 1988, 67:493-500.
4. Alenghat T., Meyers K., Mullican S.E., Leitner K., Adeniji-Adele A., Avila J., et al. Nuclear receptor corepressor and histone deacetylase 3 govern circadian metabolic physiology. Nature 2008, 456:997-1000.
5. Barbour L.A., Mizanoor Rahman S., Gurevich I., Wayne Leitner J., Fischer S.J., Roper M.D., et al. Increased P85α is a potent negative regulator of skeletal muscle insulin signaling and induces in vivo insulin resistance associated with growth hormone excess. J. Biol. Chem 2005, 280:37489-37494.
6. Barish G.D., Yu R.T., Karunasiri M., Ocampo C.B., Dixon J., Benner C., et al. Bcl-6 and NF-kappaB cistromes mediate opposing regulation of the innate immune response. Genes Dev 2010, 24:2760-2765.
7. Barish G.D., Yu R.T., Karunasiri M.S., Becerra D., Kim J., Tseng T.W., et al. The Bcl6-SMRT/NCoR cistrome represses inflammation to attenuate atherosclerosis. Cell Metab 2012, 15:554-562.
8. Baron B.W., Stanger R.R., Hume E., Sadhu A., Mick R., Kerckaert J.P., et al. BCL6 encodes a sequence-specific DNA-binding protein. Genes Chromosomes Cancer 1995, 13:221-224.
9. Barros P., Lam E.W., Jordan P., Matos P. Rac1 signalling modulates a STAT5/BCL-6 transcriptional switch on cell-cycle-associated target gene promoters. Nucleic Acids Res 2012, 40:7776-7787.
10. Basso K., Dalla-Favera R. BCL6: master regulator of the germinal center reaction and key oncogene in B cell lymphomagenesis. Adv. Immunol 2010, 105:193-210.
11. Bereshchenko O.R., Gu W., Dalla-Favera R. Acetylation inactivates the transcriptional repressor BCL6. Nat. Genet 2002, 32:606-613.
12. Berger S.L. Histone modifications in transcriptional regulation. Curr. Opin. Genet. Dev 2002, 12:142-148.
13. Cerchietti L.C., Hatzi K., Caldas-Lopes E., Yang S.N., Figueroa M.E., Morin R.D., et al. BCL6 repression of EP300 in human diffuse large B cell lymphoma cells provides a basis for rational combinatorial therapy. J. Clin. Invest 2010, 120:4569-4582.
14. Cesena T.I., Cardinaux J.R., Kwok R., Schwartz J. CCAAT/enhancer-binding protein (C/EBP) beta is acetylated at multiple lysines: acetylation of C/EBP beta at lysine 39 modulates its ability to activate transcription. J. Biol. Chem 2007, 282:956-967.
15. Cesena T.I., Cui T.X., Piwien-Pilipuk G., Kaplani J.I., Calinescu A.A., Huo J.S., et al. Multiple mechanisms of growth hormone-regulated gene transcription. Mol. Genet. Metab 2007, 90:126-133.
16. Chang C.C., Ye B.H., Chaganti R.S., Dalla-Favera R. BCL-6, a POZ/zinc-finger protein, is a sequence-specific transcriptional repressor. Proc. Natl. Acad. Sci. USA 1996, 93:6947-6952.
17. Chen Y., Lin G., Huo J.S., Barney D., Wang Z., Livshiz T., et al. Computational and functional analysis of growth hormone (GH)-regulated genes identifies the transcriptional repressor B-cell lymphoma 6 (Bc16) as a participant in GH-regulated transcription. Endocrinology 2009, 150:3645-3654.
18. Chia D.J., Rotwein P. Defining the epigenetic actions of growth hormone: acute chromatin changes accompany GH-activated gene transcription. Mol. Endocrinol 2010, 24:2038-2049.
19. Chia D.J., Varco-Merth B., Rotwein P. Dispersed chromosomal Stat5b-binding elements mediate growth hormone-activated insulin-like growth factor-I gene transcription. J. Biol. Chem 2010, 285:17636-17647.
20. Cohen D.H., LeRoith D. Obesity, type 2 diabetes, and cancer: the insulin and IGF connection. Endocr. Relat. Cancer 2012, 19:F27-F45.
21. Conforto T.L., Zhang Y., Sherman J., Waxman D.J. Impact of CUX2 on the female mouse liver transcriptome: activation of female-biased genes and repression of male-biased genes. Mol. Cell. Biol 2012, 32:4611-4627.
22. Cotto M., Cabanillas F., Tirado M., Garcia M.V., Pacheco E. Epigenetic therapy of lymphoma using histone deacetylase inhibitors. Clin. Transl. Oncol 2010, 12:401-409.
23. Croker B.A., Kiu H., Nicholson S.E. SOCS regulation of the JAK/STAT signalling pathway. Semin. Cell Dev. Biol 2008, 19:414-422.
24. Cui T.X., Piwien-Pilipuk G., Huo J.S., Kaplani J., Kwok R., Schwartz J. Endogenous CCAAT/enhancer binding protein β and p300 are both regulated by growth hormone to mediate transcriptional activation. Mol. Endocrinol 2005, 19:2175-2186.
25. Cui T.X., Kwok R., Schwartz J. Cooperative regulation of endogenous cAMP-response element binding protein and CCAAT/enhancer-binding protein beta in GH-stimulated c-fos expression. J. Endocrinol 2008, 196:89-100.
26. Cui T.X., Lin G., LaPensee C.R., Calinescu A.A., Rathore M., Streeter C., et al. C/EBPβ mediates growth hormone-regulated expression of multiple target genes. Mol. Endocrinol 2011, 25:681-693.
27. Cunliffe V.T. Eloquent silence: developmental functions of class I histone deacetylases. Curr. Opin. Genet. Dev 2008, 18:404-410.
28. Dent A.L., Shaffer A.L., Yu X., Allman D., Staudt L.M. Control of inflammation, cytokine expression, and germinal center formation by BCL-6. Science 1997, 276:589-592.
29. Dent A.L., Vasanwala F.H., Toney L.M. Regulation of gene expression by the proto-oncogene BCL-6. Crit. Rev. Oncol. Hematol 2002, 41:1-9.
30. Dhordain P., Albagli O., Lin R.J., Ansieau S., Quief S., Leutz A., et al. Corepressor SMRT binds the BTB/POZ repressing domain of the LAZ3/BCL6 oncoprotein. Proc. Natl. Acad. Sci. USA 1997, 94:10762-10767.
31. Dhordain P., Lin R.J., Quief S., Lantoine D., Kerckaert J.P., Evans R.M., et al. The LAZ3(BCL-6) oncoprotein recruits a SMRT/mSIN3A/histone deacetylase containing complex to mediate transcriptional repression. Nucleic Acids Res 1998, 26:4645-4651.
32. Diehl S.A., Schmidlin H., Nagasawa M., van Haren S.D., Kwakkenbos M.J., Yasuda E., et al. STAT3-mediated up-regulation of BLIMP1 Is coordinated with BCL6 down-regulation to control human plasma cell differentiation. J. Immunol 2008, 180:4805-4815.
33. Erickson R.L., Hemati N., Ross S.E., MacDougald O.A. p300 coactivates the adipogenic transcription factor CCAAT/enhancer-binding protein alpha. J. Biol. Chem 2001, 276:16348-16355.
34. Feng D., Liu T., Sun Z., Bugge A., Mullican S.E., Alenghat T., et al. A circadian rhythm orchestrated by histone deacetylase 3 controls hepatic lipid metabolism. Science 2011, 331:1315-1319.
35. Fernandez de Mattos S., Essafi A., Soeiro I., Pietersen A.M., Birkenkamp K.U., Edwards C.S., et al. FoxO3a and BCR-ABL regulate cyclin D2 transcription through a STAT5/BCL6-dependent mechanism. Mol. Cell. Biol 2004, 24:10058-10071.
36. Fischle W., Kiermer V., Dequiedt F., Verdin E. The emerging role of class II histone deacetylases. Biochem. Cell Biol 2001, 79:337-348.
37. Fischle W., Dequiedt F., Hendzel M.J., Guenther M.G., Lazar M.A., Voelter W., et al. Enzymatic activity associated with class II HDACs is dependent on a multiprotein complex containing HDAC3 and SMRT/N-CoR. Mol. Cell 2002, 9:45-57.
38. Gingras S., Simard J., Groner B., Pfitzner E. p300/CBP is required for transcriptional induction by interleukin-4 and interacts with Stat6. Nucleic Acids Res 1999, 27:2722-2729.
39. Glauser D.A., Schlegel W. The FoxO/Bcl-6/cyclin D2 pathway mediates metabolic and growth factor stimulation of proliferation in Min6 pancreatic β-cells. J. Recept. Signal Transduct. Res 2009, 29:293-298.
40. Goodman H.M. Growth hormone and the metabolism of carbohydrate and lipid in adipose tissue. Ann. N. Y. Acad. Sci 1968, 148:419-440.
41. Grimley P.M., Dong F., Rui H. Stat5a and Stat5b: fraternal twins of signal transduction and transcriptional activation. Cytokine Growth Factor Rev 1999, 10:131-157.
42. Grunstein M. Histone acetylation in chromatin structure and transcription. Nature 1997, 389:349-352.
43. Guenther M.G., Barak O., Lazar M.A. The SMRT and N-CoR corepressors are activating cofactors for histone deacetylase 3. Mol. Cell. Biol 2001, 21:6091-6101.
44. Hartatik T., Okada S., Okabe S., Arima M., Hatano M., Tokuhisa T. Binding of BAZF and Bc16 to STAT6-binding DNA sequences. Biochem. Biophys. Res. Commun 2001, 284:26-32.
45. Hatzi K., Jiang Y., Huang C., Garrett-Bakelman F., Gearhart M.D., Giannopoulou E.G., et al. A hybrid mechanism of action for BCL6 in B cells defined by formation of functionally distinct complexes at enhancers and promoters. Cell Rep 2013, 4:578-588.
46. Heltemes-Harris L.M., Farrar M.A. The role of STAT5 in lymphocyte development and transformation. Curr. Opin. Immunol 2012, 24:146-152.
47. Hennighausen L., Robinson G.W. Interpretation of cytokine signaling through the transcription factors STAT5A and STAT5B. Genes Dev 2008, 22:711-721.
48. Herrington J., Smit L.S., Schwartz J., Carter-Su C. The role of STAT proteins in growth hormone signaling. Oncogene 2000, 19:2585-2597.
49. Huo J.S., McEachin R.C., Cui T.X., Duggal N.K., Hai T., States D.J., et al. Profiles of growth hormone (GH)-regulated genes reveal time-dependent responses and identify a mechanism for regulation of activating transcription factor 3 by GH. J. Biol. Chem 2006, 281:4132-4141.
50. Huynh K.D., Bardwell V.J. The BCL-6 POZ domain and other POZ domains interact with the co-repressors N-CoR and SMRT. Oncogene 1998, 17:2473-2484.
51. Huynh K.D., Fischle W., Verdin E., Bardwell V.J. BCoR, a novel corepressor involved in BCL-6 repression. Genes Dev 2000, 14:1810-1823.
52. Icardi L., De Bosscher K., Tavernier J. The HAT/HDAC interplay: multilevel control of STAT signaling. Cytokine Growth Factor Rev 2012, 23:283-291.
53. Icardi L., Mori R., Gesellchen V., Eyckerman S., De Cauwer L., Verhelst J., et al. The Sin3a repressor complex is a master regulator of STAT transcriptional activity. Proc. Natl. Acad. Sci. USA 2012, 109:12058-12063.
54. Ihle J.N. STATs: signal transducers and activators of transcription. Cell 1996, 84:331-334.
55. Ikeda A., Chang K.T., Matsumoto Y., Furuhata Y., Nishihara M., Sasaki F., et al. Obesity and insulin resistance in human growth hormone transgenic rats. Endocrinology 1998, 139:3057-3063.
56. Jardin F., Ruminy P., Bastard C., Tilly H. The BCL6 proto-oncogene: a leading role during germinal center development and lymphomagenesis. Pathol. Biol. (Paris) 2007, 55:73-83.
57. Kabotyanski E.B., Huetter M., Xian W., Rijnkels M., Rosen J.M. Integration of prolactin and glucocorticoid signaling at the beta-casein promoter and enhancer by ordered recruitment of specific transcription factors and chromatin modifiers. Mol. Endocrinol 2006, 20:2355-2368.
58. Kang K., Robinson G.W., Hennighausen L. Comprehensive meta-analysis of Signal Transducers and Activators of Transcription (STAT) genomic binding patterns discerns cell-specific cis-regulatory modules. BMC Genomics 2013, 14:4.
59. Karnik S.K., Chen H., McLean G.W., Heit J.J., Gu X., Zhang A.Y., et al. Menin controls growth of pancreatic β-cells in pregnant mice and promotes gestational diabetes mellitus. Science 2007, 318:806-809.
60. Kile B.T., Schulman B.A., Alexander W.S., Nicola N.A., Martin H.M., Hilton D.J. The SOCS box: a tale of destruction and degradation. Trends Biochem. Sci 2002, 27:235-241.
61. Kojima S., Hatano M., Okada S., Fukuda T., Toyama Y., Yuasa S., et al. Testicular germ cell apoptosis in Bcl6-deficient mice. Development 2001, 128:57-65.
62. Krebs C.J., Schultz D.C., Robins D.M. The KRAB zinc finger protein RSL1 regulates sex- and tissue-specific promoter methylation and dynamic hormone-responsive chromatin configuration. Mol. Cell. Biol 2012, 32:3732-3742.
63. Kumar R., Wang R.A., Barnes C.J. Coregulators and chromatin remodeling in transcriptional control. Mol. Carcinog 2004, 41:221-230.
64. Laz E.V., Sugathan A., Waxman D.J. Dynamic in vivo binding of STAT5 to growth hormone-regulated genes in intact rat liver. Sex-specific binding at low- but not high-affinity STAT5 sites. Mol. Endocrinol 2009, 23:1242-1254.
65. Ling L., Lobie P.E. RhoA/ROCK activation by growth hormone abrogates p300/histone deacetylase 6 repression of Stat5-mediated transcription. J. Biol. Chem 2004, 279:32737-32750.
66. Litterst C.M., Kliem S., Marilley D., Pfitzner E. NCoA-1/SRC-1 is an essential coactivator of STAT5 that binds to the FDL motif in the alpha-helical region of the STAT5 transactivation domain. J. Biol. Chem 2003, 278:45340-45351.
67. Litterst C.M., Kliem S., Lodrini M., Pfitzner E. Coactivators in gene regulation by STAT5. Vitam. Horm 2005, 70:359-386.
68. Lonard D.M., O'Malley B.W. Nuclear receptor coregulators: judges, juries, and executioners of cellular regulation. Mol. Cell 2007, 27:691-700.
69. Luo G., Yu-Lee L. Stat5b inhibits NFκB-mediated signaling. Mol. Endocrinol 2000, 14:114-123.
70. Mandal M., Powers S.E., Maienschein-Cline M., Bartom E.T., Hamel K.M., Kee B.L., et al. Epigenetic repression of the Igk locus by STAT5-mediated recruitment of the histone methyltransferase Ezh2. Nat. Immunol 2011, 12:1212-1220.
71. Mascle X., Albagli O., Lemercier C. Point mutations in BCL6 DNA-binding domain reveal distinct roles for the six zinc fingers. Biochem. Biophys. Res. Commun 2003, 300:391-396.
72. Matsumoto A., Masuhara M., Mitsui K., Yokouchi M., Ohtsubo M., Misawa H., et al. CIS, a cytokine inducible SH2 protein, is a target of the JAK-STAT5 pathway and modulates STAT5 activation. Blood 1997, 89:3148-3154.
73. Mendez L.M., Polo J.M., Yu J.J., Krupski M., Ding B.B., Melnick A., et al. CtBP is an essential corepressor for BCL6 autoregulation. Mol. Cell. Biol 2008, 28:2175-2186.
74. Meyer R.D., Laz E.V., Su T., Waxman D.J. Male-specific hepatic Bcl6: growth hormone-induced block of transcription elongation in females and binding to target genes inversely coordinated with STAT5. Mol. Endocrinol 2009, 23:1914-1926.
75. Moriyama M., Yamochi T., Semba K., Akiyama T., Mori S. BCL-6 is phosphorylated at multiple sites in its serine- and proline-clustered region by mitogen-activated protein kinase (MAPK) in vivo. Oncogene 1997, 14:2465-2474.
76. Narlikar G.J., Fan H.Y., Kingston R.E. Cooperation between complexes that regulate chromatin structure and transcription. Cell 2002, 108:475-487.
77. Nelson E.A., Walker S.R., Alvarez J.V., Frank D.A. Isolation of unique STAT5 targets by chromatin immunoprecipitation-based gene identification. J. Biol. Chem 2004, 279:54724-54730.
78. Niu H., Ye B.H., Dalla-Favera R. Antigen receptor signaling induces MAP kinase-mediated phosphorylation and degradation of the BCL-6 transcription factor. Genes Dev 1998, 12:1953-1961.
79. O'Malley B.W., Malovannaya A., Qin J. Minireview: nuclear receptor and coregulator proteomics - 2012 and beyond. Mol. Endocrinol 2012, 26:1646-1650.
80. Ono M., Chia D.J., Merino-Martinez R., Flores-Morales A., Unterman T.G., Rotwein P. Signal transducer and activator of transcription (Stat) 5b-mediated inhibition of insulin-like growth factor binding protein-1 gene transcription: a mechanism for repression of gene expression by growth hormone. Mol. Endocrinol 2007, 21:1443-1457.
81. Pasqualucci L., Migliazza A., Basso K., Houldsworth J., Chaganti R.S., Dalla-Favera R. Mutations of the BCL6 proto-oncogene disrupt its negative autoregulation in diffuse large B-cell lymphoma. Blood 2003, 101:2914-2923.
82. Pasqualucci L., Dominguez-Sola D., Chiarenza A., Fabbri G., Grunn A., Trifonov V., et al. Inactivating mutations of acetyltransferase genes in B-cell lymphoma. Nature 2011, 471:189-195.
83. Paulson M., Pisharody S., Pan L., Guadagno S., Mui A.L., Levy D.E. Stat protein transactivation domains recruit p300/CBP through widely divergent sequences. J. Biol. Chem 1999, 274:25343-25349.
84. Perissi V., Aggarwal A., Glass C.K., Rose D.W., Rosenfeld M.G. A corepressor/coactivator exchange complex required for transcriptional activation by nuclear receptors and other regulated transcription factors. Cell 2004, 116:511-526.
85. Perry J.K., Mohankumar K.M., Emerald B.S., Mertani H.C., Lobie P.E. The contribution of growth hormone to mammary neoplasia. J. Mammary Gland Biol. Neoplasia 2008, 13:131-145.
86. Pfitzner E., Jahne R., Wissler M., Stoecklin E., Groner B. p300/CREB-binding protein enhances the prolactin-mediated transcriptional induction through direct interaction with the transactivation domain of Stat5, but does not participate in the Stat5-mediated suppression of the glucocorticoid response. Mol. Endocrinol 1998, 12:1582-1593.
87. Qin Z.S., Yu J., Shen J., Maher C.A., Hu M., Kalyana-Sundaram S., et al. HPeak: an HMM-based algorithm for defining read-enriched regions in ChIP-Seq data. BMC Bioinformatics 2010, 11:369.
88. Ramachandrareddy H., Bouska A., Shen Y., Ming J., Rizzino A., Chan W.C., et al. BCL6 promoter interacts with far upstream sequences with greatly enhanced activating histone modifications in germinal center B cells. Proc. Natl. Acad. Sci. USA 2010, 107:11930-11935.
89. Rascle A., Johnston J.A., Amati B. Deacetylase activity is required for recruitment of the basal transcription machinery and transactivation by STAT5. Mol. Cell. Biol 2003, 23:4162-4173.
90. Roeder R.G. Transcriptional regulation and the role of diverse coactivators in animal cells. FEBS Lett 2005, 579:909-915.
91. Rosenfeld M.G., Lunyak V.V., Glass C.K. Sensors and signals: a coactivator/corepressor/epigenetic code for integrating signal-dependent programs of transcriptional response. Genes Dev 2006, 20:1405-1428.
92. Ruthenburg A.J., Li H., Patel D.J., Allis C.D. Multivalent engagement of chromatin modifications by linked binding modules. Nat. Rev. Mol. Cell Biol 2007, 8:983-994.
93. Schebesta M., Heavey B., Busslinger M. Transcriptional control of B-cell development. Curr. Opin. Immunol 2002, 14:216-223.
94. Scheeren F.A., Naspetti M., Diehl S., Schotte R., Nagasawa M., Wijnands E., et al. STAT5 regulates the self-renewal capacity and differentiation of human memory B cells and controls Bcl-6 expression. Nat. Immunol 2005, 6:303-313.
95. Sebastián C., Serra M., Yeramian A., Serrat N., Lloberas J., Celada A. Deacetylase activity is required for STAT5-dependent GM-CSF functional activity in macrophages and differentiation to dendritic cells. J. Immunol 2008, 180:5898-5906.
96. Seyfert V.L., Allman D., He Y., Staudt L.M. Transcriptional repression by the proto-oncogene BCL-6. Oncogene 1996, 12:2331-2342.
97. Staudt L.M., Dent A.L., Shaffer A.L., Yu X. Regulation of lymphocyte cell fate decisions and lymphomagenesis by BCL-6. Int. Rev. Immunol 1999, 18:381-403.
98. Strahl B.D., Allis C.D. The language of covalent histone modifications. Nature 2000, 403:41-45.
99. Tannenbaum G.S., Choi H.K., Gurd W., Waxman D.J. Temporal relationship between the sexually dimorphic spontaneous GH secretory profiles and hepatic STAT5 activity. Endocrinology 2001, 142:4599-4606.
100. Teglund S., McKay C., Schuetz E., van Deursen J.M., Stravopodis D., Wang D., et al. Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses. Cell 1998, 93:841-850.
101. Tran T.H., Utama F.E., Lin J., Yang N., Sjolund A.B., Ryder A., et al. Prolactin inhibits Bcl6 expression in breast cancer through a Stat5a-dependent mechanism. Cancer Res 2010, 70:1711-1721.
102. Vidal O.M., Merino R., Rico-Bautista E., Fernandez-Perez L., Chia D.J., Woelfle J., et al. In vivo transcript profiling and phylogenetic analysis identifies suppressor of cytokine signaling 2 as a direct signal transducer and activator of transcription 5b target in liver. Mol. Endocrinol 2007, 21:293-311.
103. Walker S.R., Nelson E.A., Frank D.A. STAT5 represses BCL6 expression by binding to a regulatory region frequently mutated in lymphomas. Oncogene 2007, 26:224-233.
104. Walker S.R., Nelson E.A., Yeh J.E., Pinello L., Yuan G.C., Frank D.A. STAT5 outcompetes STAT3 to regulate the expression of the oncogenic transcriptional modulator BCL6. Mol. Cell. Biol 2013, 33:2879-2890.
105. Wang J., Lazar M.A. Bifunctional role of Rev-erbalpha in adipocyte differentiation. Mol. Cell. Biol 2008, 28:2213-2220.
106. Waters M.J., Hoang H.N., Fairlie D.P., Pelekanos R.A., Brown R.J. New insights into growth hormone action. J. Mol. Endocrinol 2006, 36:1-7.
107. Woelfle J., Rotwein P. In vivo regulation of growth hormone-stimulated gene transcription by STAT5b. Am. J. Physiol. Endocrinol. Metab 2004, 286:E393-E401.
108. You S.H., Lim H.W., Sun Z., Broache M., Won K.J., Lazar M.A. Nuclear receptor co-repressors are required for the histone-deacetylase activity of HDAC3 in vivo. Nat. Struct. Mol. Biol 2013, 20:182-187.
109. Zhang Y., Laz E.V., Waxman D.J. Dynamic, sex-differential STAT5 and BCL6 binding to sex-biased, growth hormone-regulated genes in adult mouse liver. Mol. Cell. Biol 2012, 32:880-896.
110. Zhu B.M., Kang K., Yu J.H., Chen W., Smith H.E., Lee D., et al. Genome-wide analyses reveal the extent of opportunistic STAT5 binding that does not yield transcriptional activation of neighboring genes. Nucleic Acids Res 2012, 40:4461-4472.